Event Session
The Truth About Pharma Patent Practices: Separating Fact and Fiction *
October 27, 2025 @ 11:50 AM EST
11:50 AM ET
October 27, 2025
The Truth About Pharma Patent Practices: Separating Fact and Fiction *
In the ongoing debate over prescription drug prices, the role of patents is often misunderstood—and sometimes deliberately misrepresented. This panel will present the perspective of brand-name pharmaceutical companies, exploring how patents support medical innovation, sustain research investment, and enable life-saving breakthroughs.
Panelists will address the myths and misinformation spread by patent critics—including the repeated distortions from organizations like I-MAK—and will walk through the real data behind drug patent portfolios. Attendees will gain a clear, fact-based understanding of how the patent system actually functions in the pharmaceutical sector, why “evergreening” is often mischaracterized, and how responsible IP strategies drive both innovation and patient access.
Materials:
Counting Patents, Not Progress: Another Misdiagnosis by I-MAK
Amgen Attacks Academics’ False Claims About Biologic Patents
Setting the Record Straight: The Truth about Patents in the Biopharmaceutical Sector
Debunked: USPTO Findings Should End False Pharma Patent Narratives
Facts, Not False Political Narratives, Should Drive American Competitiveness
SURVEY:
https://www.surveymonkey.com/r/The-Truth-About-Pharma-Patent-Practices
In the ongoing debate over prescription drug prices, the role of patents is often misunderstood—and sometimes deliberately misrepresented. This panel will present the perspective of brand-name pharmaceutical companies, exploring how patents support medical innovation, sustain research investment, and enable life-saving breakthroughs. Panelists will address the myths and misinformation spread by patent critics—including the repeated distortions from organizations like I-MAK—and will…
Session Speakers
Joshua Kresh
Research Professor, Executive Director
The IP Policy Institute, The University of Akron School of Law